2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine
Modify Date: 2024-01-20 09:38:57
![2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine Structure](https://www.chemsrc.com/caspic/467/882435-02-1.png)
2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine structure
|
Common Name | 2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine | ||
|---|---|---|---|---|
| CAS Number | 882435-02-1 | Molecular Weight | 398.42 | |
| Density | 1.7±0.1 g/cm3 | Boiling Point | 771.8±70.0 °C at 760 mmHg | |
| Molecular Formula | C19H22N6O4 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | 420.6±35.7 °C | |
Use of 2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 9-(2-Deoxy-β-D-erythro-pentofuranosyl)-2-[2-(3-pyridinyl)-1-pyrrolidinyl]-9H-purin-6-ol |
|---|---|
| Synonym | More Synonyms |
| Description | 2-[(3-Pyridyl) pyrrolidin-1-yl]-2’-deoxyinosine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Density | 1.7±0.1 g/cm3 |
|---|---|
| Boiling Point | 771.8±70.0 °C at 760 mmHg |
| Molecular Formula | C19H22N6O4 |
| Molecular Weight | 398.42 |
| Flash Point | 420.6±35.7 °C |
| Exact Mass | 398.170258 |
| LogP | -0.85 |
| Vapour Pressure | 0.0±2.8 mmHg at 25°C |
| Index of Refraction | 1.813 |
| 9H-Purin-6-ol, 9-(2-deoxy-β-D-erythro-pentofuranosyl)-2-[2-(3-pyridinyl)-1-pyrrolidinyl]- |
| 9-(2-Deoxy-β-D-erythro-pentofuranosyl)-2-[2-(3-pyridinyl)-1-pyrrolidinyl]-9H-purin-6-ol |